Mr. Speaker, I remember being on the same side of the House with the Prime Minister when he was criticizing the very law he just defended.
Could the Prime Minister tell us why his Minister for International Trade, in respect of talks having to do with the trade related intellectual property rights talks, is siding with the United States when the big multinational drug companies are trying to stop the easy flow of generic drugs into developing countries? Why are we doing that when we have just experienced how difficult those patent laws can be for public health?